In multiple CRC case studies, AI-HOPE-PM demonstrated the ability to reveal associations between genomic alterations (eg, TP53 and APC mutations), treatment exposures (eg, FOLFOX chemotherapy), and SDOH variables such as financial strain, food insecurity, health care access, and social support. Here, TP53 is linked to colorectal carcinoma.